Penserra Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7K Sell
18
-1,117
-98% -$434K ﹤0.01% 845
2025
Q1
$492K Sell
1,135
-536
-32% -$232K 0.01% 596
2024
Q4
$614K Buy
1,671
+562
+51% +$207K 0.01% 524
2024
Q3
$576K Buy
1,109
+13
+1% +$6.75K 0.01% 505
2024
Q2
$594K Sell
1,096
-5
-0.5% -$2.71K 0.01% 551
2024
Q1
$570K Sell
1,101
-1,029
-48% -$533K 0.01% 554
2023
Q4
$1M Sell
2,130
-426
-17% -$201K 0.02% 378
2023
Q3
$1.11M Sell
2,556
-155
-6% -$67.4K 0.02% 337
2023
Q2
$1.2M Buy
2,711
+1,397
+106% +$620K 0.02% 356
2023
Q1
$603K Buy
1,314
+55
+4% +$25.2K 0.01% 459
2022
Q4
$645K Buy
1,259
+100
+9% +$51.2K 0.01% 476
2022
Q3
$526K Buy
1,159
+30
+3% +$13.6K 0.01% 415
2022
Q2
$544K Sell
1,129
-76
-6% -$36.6K 0.01% 462
2022
Q1
$591K Buy
1,205
+46
+4% +$22.6K 0.01% 474
2021
Q4
$536K Buy
1,159
+196
+20% +$90.6K 0.01% 522
2021
Q3
$358K Buy
963
+108
+13% +$40.2K 0.01% 553
2021
Q2
$325K Buy
855
+222
+35% +$84.4K 0.01% 560
2021
Q1
$227K Buy
633
+100
+19% +$35.9K ﹤0.01% 559
2020
Q4
$171K Buy
533
+91
+21% +$29.2K ﹤0.01% 556
2020
Q3
$118K Sell
442
-7,900
-95% -$2.11M ﹤0.01% 472
2020
Q2
$2.19M Buy
8,342
+7,965
+2,113% +$2.09M 0.11% 170
2020
Q1
$103K Buy
377
+14
+4% +$3.83K 0.01% 562
2019
Q4
$95K Buy
363
+183
+102% +$47.9K 0.01% 614
2019
Q3
$48K Buy
+180
New +$48K ﹤0.01% 681
2017
Q1
Sell
-147
Closed -$21K 639
2016
Q4
$21K Buy
147
+31
+27% +$4.43K ﹤0.01% 592
2016
Q3
$14K Buy
116
+46
+66% +$5.55K ﹤0.01% 741
2016
Q2
$9K Buy
70
+23
+49% +$2.96K ﹤0.01% 726
2016
Q1
$6 Sell
47
-1
-2% ﹤0.01% 630
2015
Q4
$7K Buy
+48
New +$7K ﹤0.01% 620